| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |